Cite

HARVARD Citation

    Hellemans, R. et al. (2017). Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti‐IL2 Receptor Monoclonal Antibodies?. American journal of transplantation. 17 (1), pp. 22-27. [Online]. 
  
Back to record